Impel considers strategic alternatives, takes out $2.5M loan to continue operatingnews2023-10-05T14:48:32+00:00October 5th, 2023|Endpoints News|
Bayer’s projects with Twist, Evotec; AbbVie buys out Parkinson’s drugmaker; A new drug discovery nonprofit in Torontonews2023-10-05T14:29:33+00:00October 5th, 2023|Endpoints News|
Why Andreessen Horowitz’s Julie Yoo sees AI as a ‘leapfrog opportunity’ for healthcarenews2023-10-05T14:09:58+00:00October 5th, 2023|Endpoints News|
UniQure halves research, lays off 20% while CSO departs in major revampnews2023-10-05T11:41:26+00:00October 5th, 2023|Endpoints News|
BMS-backed liquid biopsy biotech Precede Biosciences debuts to enhance precision medicine approachesnews2023-10-05T11:00:23+00:00October 5th, 2023|Endpoints News|
Health tech startup Atropos reveals generative AI tool for parsing patient recordsnews2023-10-05T11:00:03+00:00October 5th, 2023|Endpoints News|
FDA imposes partial clinical hold on Innate Pharma’s cancer drug trials after adverse reaction and patient deathnews2023-10-05T10:35:19+00:00October 5th, 2023|Endpoints News|
Kyowa Kirin to acquire gene therapy developer Orchard Therapeutics for $387M cashnews2023-10-05T09:24:48+00:00October 5th, 2023|Endpoints News|
EQRx had limited buyer interest, tried acquiring other companies before Revolution came for its cashnews2023-10-04T21:12:53+00:00October 4th, 2023|Endpoints News|
FDA’s oncology advisory committee backs potential high-risk neuroblastoma treatmentnews2023-10-04T19:47:42+00:00October 4th, 2023|Endpoints News|
